Ongoing sensory or motor neuropathy Grade ?2.
No grade >= 2 peripheral motor or sensory neuropathy
Neuropathy (sensory and motor) =< CTCAE v 3.0 grade 1
Neuropathy (sensory and motor) less than or equal to CTCAE grade 1
Patients must have < grade 2 neuropathy (sensory/motor) within 7 days prior to registration
Subject has preexisting sensory or motor neuropathy Grade ? 2 at baseline
Participants with grade >= 3 peripheral motor or sensory neuropathy
Neuropathy (sensory and motor) NCI CTCAE grade =< 2
Neuropathy (sensory and motor) less than or equal to CTCAE v4.0, grade 1
Patients who have pre-existing motor or sensory neuropathy of a severity ? grade 1 by CTCAE v4.0 criteria
Nervous system disorder (paresthesias, peripheral motor neuropathy, or peripheral sensory neuropathy) ? Grade 2, per the CTCAE v4.0.
Grade ? 3 sensory or motor neuropathy.
Has not recovered from adverse reactions to prior myeloma treatment or procedures (chemotherapy, immunotherapy, radiation therapy) to NCI CTCAE less than or equal to (<=) Grade 1 or baseline, except for sensory or motor neuropathy which should have recovered to <=Grade 2 or baseline.
Sensory or motor neuropathy ? grade 2
Preexisting motor neuropathy Grade ? 2
Neuropathy (sensory and motor) less than or equal to CTCAE v4.03 grade 1
Sensory or motor neuropathy >= grade 2
Ongoing sensory or motor neuropathy Grade 2 or higher.
Sensory or motor neuropathy >= Grade 2.
Neuropathy (sensory and motor) =< to CTCAE grade 1
Patients with symptomatic peripheral motor or sensory neuropathy >= grade 2 at baseline will receive radiation therapy alone
Neuropathy (sensory and motor) less than or equal to grade 1 per Common Toxicity Criteria (CTC) version 4
Grade 3 sensory neuropathy or motor neuropathy with pain
Sensory/motor neuropathy >= grade 2
Sensory/motor neuropathy >= grade 2
Patients with any of the following adverse events at the time of enrollment are not eligible:\r\n* Grade ? 2 motor, sensory or peripheral neuropathy\r\n* Grade ? 3 hyponatremia (serum sodium [Na] ? 130 mmol/L)
Participant must have either no neuropathy (sensory and motor) or neuropathy less than or equal to grade 1
Patients with persistent grade 2 or higher peripheral sensory or motor neuropathy of any cause
Sensory or motor peripheral neuropathy >= grade 2
Sensory or motor neuropathy >= grade 2
Subject has preexisting sensory or motor neuropathy Grade ? 2 at baseline
Pre-existing >= grade 2 sensory or motor peripheral neurotoxicity
Motor peripheral neuropathy = grade 0 (per CTCAE v. 4.0)
Patients must not have a pre-existing > grade 1 motor or sensory neuropathy
PHASE II: Patients must not have a pre-existing > grade 1 motor or sensory neuropathy
Neuropathy (sensory and motor) =< grade 1
Neuropathy (sensory and motor) less than or equal to CTEP CTCAE version 4.0, grade 1
Pre-existing peripheral motor or sensory neuropathy >= grade 2
Neuropathy (sensory and motor) less than or equal to Grade 1.
Preexisting sensory neuropathy Grade ? 2 or motor neuropathy Grade ? 2
Motor neuropathy considered of autoimmune origin
Sensory or motor peripheral neuropathy
Neuropathy (sensory and motor) less than or equal to grade 1
Neuropathy (sensory and motor) less than or equal to grade 1
Preexisting sensory and/or motor neuropathy Grade ? 2
History of severe motor or sensory neuropathy, or any other autoimmune disorder which is deemed to be significant
CTC Grade 1 or greater neuropathy (motor or sensory) from comorbidity other than prior taxane exposure, such as diabetes.
Neuropathy (sensory and motor) less than or equal to CTCAE grade 1
Neuropathy(Both motor and sensory) ? Grade1 (CTCAE Version 4.0)
Neuropathy (sensory and motor) =< grade 1 according to Common Toxicity Criteria for Adverse Events version 3 (CTCAE)
Neuropathy (sensory and motor) less than or equal to grade 1
Neuropathy (sensory and motor) less than or equal to CTCAE v 4.0 grade 1
Patients with pre-existing Grade 2 (or greater) peripheral motor or sensory neurotoxicity per the CTCAE 3.0 as determined by the treating physician or a neurologist.
Evidence of baseline sensory or motor neuropathy
Neuropathy (sensory and motor) =< CTCAE v4.03 grade 1
Significant peripheral sensory or motor neuropathy at the start of the study.
Has sensory or motor neuropathy limiting daily activities.
Neurologic function: neuropathy (sensory and motor) ? CTCAE Grade 1
Current/ongoing Neuropathy (sensory or motor) Grade > 1 or any history of Grade ? 3 neuropathy with prior Vincristine or chemotherapy exposure (documentation by history is adequate to exclude)
Greater than grade 2 motor neuropathy or greater than grade 3 sensory neuropathy at screening
Neuropathy (sensory and motor) less than or equal to CTCAE grade 1
Grade 2 or greater motor or sensory neuropathy
Patient does not have a clinically significant neurologic deficit or objective peripheral neuropathy (greater than or equal to grade 2); peripheral (sensory or motor) neuropathy related to limb sparing procedure or amputation is allowed
Patients with >= grade 2 sensory or motor neuropathy are not eligible
Neuropathy (sensory or motor) less than or equal to grade 1
Able to perform motor/sensory tests
Sensory/motor neuropathy ? Grade 2
Current or prior history of grade ? 2 peripheral sensory and/or motor neuropathy.